Literature DB >> 25341845

Exacerbation of intracranial aneurysm and aortic dissection in hypertensive rat treated with the prostaglandin F-receptor antagonist AS604872.

Miyuki Fukuda1, Tomohiro Aoki, Toshiaki Manabe, Akiko Maekawa, Takayuki Shirakawa, Hiroharu Kataoka, Yasushi Takagi, Susumu Miyamoto, Shuh Narumiya.   

Abstract

Intracranial aneurysm (IA) and aortic dissection are both complications of hypertension and characterized by degeneration of the media. Given the involvement of prostaglandin F2α and its receptor, FP, in extracellular matrix remodeling in a mouse model of pulmonary fibrosis, here we induced hypertension and IA in rats by salt loading and hemi-lateral ligation of renal and carotid arteries and examined effects of a selective FP antagonist, AS604872, on these vascular events. AS604872 significantly accelerated degeneration of the media in both cerebral artery and aorta as evidenced by thinning of the media and disruption of the elastic lamina and promoted IA and aortic dissection. Notably, AS604872 induced expression of pro-inflammatory genes such as E-selectin in lesions and significantly enhanced macrophage infiltration. Suppression of surface expression of E-selectin with cimetidine prevented macrophage infiltration and aortic dissection. Thus, AS604872 exacerbates vascular inflammation in hypertensive rats and facilitates IA and aortic dissection. These results demonstrate that both IA and aortic dissection are caused by chronic inflammation of the arterial wall, which is worsened by AS604872, cautioning that other FP antagonists may share such deleterious actions in vascular homeostasis and suggesting that AS604872 can be used to make models of these vascular diseases with extensive degeneration.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25341845     DOI: 10.1254/jphs.14148fp

Source DB:  PubMed          Journal:  J Pharmacol Sci        ISSN: 1347-8613            Impact factor:   3.337


  10 in total

Review 1.  Experimental in vivo and ex vivo models for the study of human aortic dissection: promises and challenges.

Authors:  Ding-Sheng Jiang; Xin Yi; Xue-Hai Zhu; Xiang Wei
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

Review 2.  Prostaglandin FP receptor antagonists: discovery, pharmacological characterization and therapeutic utility.

Authors:  Najam A Sharif; Peter G Klimko
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

Review 3.  Neuroaxonal and cellular damage/protection by prostanoid receptor ligands, fatty acid derivatives and associated enzyme inhibitors.

Authors:  Najam A Sharif
Journal:  Neural Regen Res       Date:  2023-01       Impact factor: 6.058

Review 4.  Regulation of inflammation by lipid mediators in oral diseases.

Authors:  S Sommakia; O J Baker
Journal:  Oral Dis       Date:  2016-08-04       Impact factor: 3.511

5.  Prevalence of Intracranial Aneurysm in Patients With Aortic Disease in Korea: A Nationwide Population-Based Study.

Authors:  Jihye Song; Yong Cheol Lim; Inseok Ko; Jong-Yeup Kim; Dong-Kyu Kim
Journal:  J Am Heart Assoc       Date:  2021-03-10       Impact factor: 5.501

Review 6.  Endogenous animal models of intracranial aneurysm development: a review.

Authors:  Vincent M Tutino; Hamidreza Rajabzadeh-Oghaz; Sricharan S Veeturi; Kerry E Poppenberg; Muhammad Waqas; Max Mandelbaum; Nicholas Liaw; Adnan H Siddiqui; Hui Meng; John Kolega
Journal:  Neurosurg Rev       Date:  2021-01-26       Impact factor: 2.800

7.  Sustained expression of MCP-1 by low wall shear stress loading concomitant with turbulent flow on endothelial cells of intracranial aneurysm.

Authors:  Tomohiro Aoki; Kimiko Yamamoto; Miyuki Fukuda; Yuji Shimogonya; Shunichi Fukuda; Shuh Narumiya
Journal:  Acta Neuropathol Commun       Date:  2016-05-09       Impact factor: 7.801

Review 8.  Preemptive Medicine for Cerebral Aneurysms.

Authors:  Tomohiro Aoki; Kazuhiko Nozaki
Journal:  Neurol Med Chir (Tokyo)       Date:  2016-04-06       Impact factor: 1.742

9.  CD40L promotes development of acute aortic dissection via induction of inflammation and impairment of endothelial cell function.

Authors:  Lu Han; Lu Dai; Yuan-Fei Zhao; Hai-Yang Li; Ou Liu; Feng Lan; Wen-Jian Jiang; Hong-Jia Zhang
Journal:  Aging (Albany NY)       Date:  2018-03-04       Impact factor: 5.682

10.  Indomethacin reduces rates of aortic dissection and rupture of the abdominal aorta by inhibiting monocyte/macrophage accumulation in a murine model.

Authors:  Shota Tomida; Kenichi Aizawa; Norifumi Nishida; Hiroki Aoki; Yasushi Imai; Ryozo Nagai; Toru Suzuki
Journal:  Sci Rep       Date:  2019-07-24       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.